Disproquima Acquires Italian Company Res Pharma to Expand Its Footprint in the Life Sciences Industry

Recently, Disproquima announced the successful acquisition of Res Pharma, a well-known Italian company specializing in providing high-quality raw materials for the cosmetics, pharmaceutical, food and nutritional products industries.

Disproquima, known for its comprehensive distribution of raw materials and ingredients in various sectors, has strategically expanded its product portfolio and strengthened its position in the global market with the acquisition of Res Pharma. The move reflects Disproquima's commitment to providing customers with a wider range of innovative, sustainable and market trend-focused solutions.

As Disproquima's operations expand to four continents, this acquisition demonstrates the company's commitment to promoting growth, innovation and excellence in the life sciences industry.

Jordi Sánchez, CEO of Disproquima, said: "We are pleased to announce the acquisition of Res Pharma, a company that shares our commitment to excellence and innovation in the life sciences industry. This strategic move allows us to enhance our capabilities and further support our customers with a comprehensive range of products and services. "

With a rich heritage spanning 60 years, Res Pharma has been a key player in carefully selecting and delivering top quality ingredients to its customers. The company’s commitment to providing comprehensive solutions covering innovation, sustainability and current market trends aligns with Disproquima’s values.

Letizia Facchini, President of Res Pharma said, this acquisition marks a new chapter for Res Pharma. Joining forces with Disproquima provides Res Pharma with new opportunities to continue delivering outstanding value to its customers. Both parties can share advantages and have a more significant impact on the global life sciences industry.

The collaboration between Disproquima and Res Pharma will leverage the collective expertise of both companies to provide customers with unparalleled sales and marketing advice, quality and regulatory support, efficient logistics and complete transparency. The alliance is expected to generate strong synergies that will benefit customers in the pharmaceutical, dietary supplement, food and beverage, personal care and animal nutrition industries.